These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1491132)

  • 1. [Ovarian hyperstimulation syndrome during in vitro fertilization stimulations. Comparison between the experience of the Center for Medically Assisted Procreation of the Saint Antoine maternity department and a review of the literature].
    Guettier X; Larue L; Chamorand E; Barbier D; Jault T; Liou Y; Marpeau L; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):887-95. PubMed ID: 1491132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
    Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
    Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome.
    Selman H; Brusco GF; Fiorini F; Barnocchi N; Mariani M; El-Danasouri I
    Fertil Steril; 2009 Apr; 91(4 Suppl):1611-3. PubMed ID: 19200960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of ovarian hyperstimulation syndrome in in-vitro-fertilization treatment over a period of 11 years].
    Niederberger V; Rottensteiner-Grohsmann C; Turnheim K; Obruca A; Brunner M; Feichtinger W
    Wien Med Wochenschr; 1995; 145(23):642-5. PubMed ID: 8578756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome.
    Avecillas JF; Falcone T; Arroliga AC
    Crit Care Clin; 2004 Oct; 20(4):679-95, ix. PubMed ID: 15388196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The ovarian hyperstimulation syndrome in pregnancy after IVF-ET].
    Kozovski I; Markova V; Andonov M
    Akush Ginekol (Sofiia); 1998; 37(2):26-7. PubMed ID: 9859531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study.
    Courbiere B; Oborski V; Braunstein D; Desparoir A; Noizet A; Gamerre M
    Fertil Steril; 2011 Apr; 95(5):1629-32. PubMed ID: 21215968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late presentation with severe ovarian hyperstimulation syndrome is diagnostic of clinical in vitro fertilization pregnancy.
    Richter KS; Van Nest RL; Stillman RJ
    Fertil Steril; 2004 Aug; 82(2):478-9. PubMed ID: 15302307
    [No Abstract]   [Full Text] [Related]  

  • 13. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
    Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
    Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
    Vrtovec HM; Tomazevic T
    J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of severe ovarian hyperstimulation syndrome after inadvertent stimulation with a gonadotropin-releasing hormone agonist and human menopausal gonadotropin in a pre-existing early pregnancy.
    Zech NH; Netzbandt P; Zech H
    Fertil Steril; 2005 Dec; 84(6):1745. PubMed ID: 16359980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovarian hyperstimulation syndrome. Current concepts].
    Kably Ambe A; Sinibaldi Gómez J; Rosete Rossetti R; Barrón Vallejo J; Serviere Zaragoza C; Villavicencio Castañeda J
    Ginecol Obstet Mex; 1994 Apr; 62():98-102. PubMed ID: 8034223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
    Zamah AM; El-Sayed YY; Milki AA
    Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal pregnancy outcome in a minimal-stimulation in vitro fertilization program.
    DeVane GW; Gangrade BK; Wilson R; Loy RA
    Am J Obstet Gynecol; 2000 Aug; 183(2):309-13; discussion 313-5. PubMed ID: 10942463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.